Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | MAP3K14 | Q99558 | 1/20 | 0.44 |
| ▸ | CRBN | Q96SW2 | 4/20 | 0.39 |
| ▸ | DDB1 | Q16531 | 3/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | APEX1 | P27695 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | ITGB3 | P05106 | 2/20 | 0.35 |
| ▸ | ITGB1 | P05556 | 2/20 | 0.35 |
| ▸ | ITGAV | P06756 | 2/20 | 0.35 |
| ▸ | ITGB2 | P05107 | 1/20 | 0.35 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.35 |
| ▸ | ITGA5 | P08648 | 1/20 | 0.35 |
| ▸ | ITGB5 | P18084 | 1/20 | 0.35 |
| ▸ | ITGAL | P20701 | 1/20 | 0.35 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cyclopropane SCHEMBL15636563 | 0.96 | ALDH1A1 (0.49) | ALDH1A1MAP3K14CRBNDDB1MEN1 | |
| SCHEMBL21658858 | 0.83 | MAP3K14 (0.46) | ALDH1A1MAP3K14CRBNDDB1MEN1 | |
| SCHEMBL2711511 | 0.81 | MAP3K14 (0.44) | ALDH1A1MAP3K14CRBNDDB1MEN1 | |
| SCHEMBL2896147 | 0.79 | MEN1 (0.47) | ALDH1A1MAP3K14CRBNDDB1MEN1 | |
| SCHEMBL6511682 | 0.79 | MAP3K14 (0.43) | ALDH1A1MAP3K14CRBNDDB1MEN1 | |
| SCHEMBL27553051 | 0.79 | MAP3K14 (0.43) | ALDH1A1MAP3K14CRBNDDB1MEN1 | |
| SCHEMBL28506463 | 0.77 | CRBN (0.56) | CRBNDDB1 | |
| SCHEMBL10832091 | 0.77 | CRBN (0.56) | CRBNDDB1 | |
| SCHEMBL28505048 | 0.77 | CRBN (0.56) | CRBNDDB1 | |
| SCHEMBL8100037 | 0.76 | MAP3K14 (0.40) | ALDH1A1MAP3K14CRBNDDB1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116790136-B | Carboxylic acid succinimide ester dye and reactive dyeing method thereof | 现代纺织技术创新中心(鉴湖实验室) | 2024-04-02 | — | — | CN | claimed |
| CN-116790136-A | Carboxylic acid succinimide ester dye and reactive dyeing method thereof | 现代纺织技术创新中心(鉴湖实验室) | 2023-09-22 | — | — | CN | claimed |
| US-20230047529-A1 | METHOD FOR SYNTHESIZING ZIRCONIUM COMPLEX | JFE ENGINEERING CORPORATION (JP) | 2023-02-16 | — | — | US | claimed |
| EP-4006015-A1 | METHOD FOR SYNTHESIZING ZIRCONIUM COMPLEX | JFE Engineering Corporation (JP) | 2022-06-01 | — | — | EP | claimed |
| CN-101899327-B | High-temperature equipment coke inhibitor and preparation and application thereof | PETROCHINA CO LTD | 2013-05-29 | — | — | CN | claimed |
| JP-8176105-A | — | — | None | — | — | JP | disclosed |
| CN-118184988-A | Preparation method of polyethylene glycol derivative and application of polyethylene glycol derivative in drug long-acting | 江苏众红生物工程创药研究院有限公司 | 2024-06-14 | — | — | CN | disclosed |
| CN-118076606-A | Imidazopyridazine IL-17 inhibitor compounds | 詹森药业有限公司 | 2024-05-24 | — | — | CN | disclosed |
| CN-116790136-B | Carboxylic acid succinimide ester dye and reactive dyeing method thereof | 现代纺织技术创新中心(鉴湖实验室) | 2024-04-02 | — | — | CN | disclosed |
| CN-116790136-B | Carboxylic acid succinimide ester dye and reactive dyeing method thereof | 现代纺织技术创新中心(鉴湖实验室) | 2024-04-02 | — | — | CN | disclosed |
| CN-116790136-A | Carboxylic acid succinimide ester dye and reactive dyeing method thereof | 现代纺织技术创新中心(鉴湖实验室) | 2023-09-22 | — | — | CN | disclosed |
| CN-116790136-A | Carboxylic acid succinimide ester dye and reactive dyeing method thereof | 现代纺织技术创新中心(鉴湖实验室) | 2023-09-22 | — | — | CN | disclosed |
| US-4741818-A | COMPLEXES | LEARONAL, INC. (US) | 1988-05-03 | — | — | US | disclosed |
| EP-0225422-A1 | Alkaline baths and methods for electrodeposition of palladium and palladium alloys | LeaRonal, Inc. (US) | 1987-06-16 | — | — | EP | disclosed |
| US-4614712-A | Immunoassays with luciferase labeled ligands or receptors | THE UPJOHN COMPANY (US) | 1986-09-30 | — | — | US | disclosed |
| US-4578378-A | (Oxoheterocyclic carbonamido)cephem carboxylic acid derivatives | SHIONOGI & CO., LTD. (JP) | 1986-03-25 | — | — | US | disclosed |
| US-4548994-A | IMMOBILIZATION ON AFFINITY RESIN | THE UPJOHN COMPANY (US) | 1985-10-22 | — | — | US | disclosed |
| EP-0057600-B1 | AFFINITY RESINS AND THEIR USE IN ISOLATING BACTERIAL LUCIFERASE | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 1985-05-08 | — | — | EP | disclosed |
| US-4412001-A | IMMOBILIZATION BY BINDING TO A LIGAND-SPACER-SUPPORT; WASHING; DESORPTION; PURIFICATION | BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 1983-10-25 | — | — | US | disclosed |
| EP-0057600-A2 | Affinity resins and their use in isolating bacterial luciferase | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 1982-08-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230047529-A1 | METHOD FOR SYNTHESIZING ZIRCONIUM COMPLEX | ZRANB2, ZFP3, ZNF787 | ALDH1A1 4708/4885MAP3K14 3001/4885CRBN 1720/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.